In 1970, Ciba and Geigy merged to form Ciba-Geigy Ltd. Ten years ... According to Novartis, the Glivec International Patient Assistance Program has provided free treatment to nearly 27,000 ...

I didn’t have money,” said Bee, who came here through the diversity immigrant visa program ... the request for prescription assistance has doubled. There are just a lot of a lot of Iowans ...

They show you the lowest available prescription price ... website to check for a program in your state. Remember that not all states offer Pharmaceutical Assistance Programs, and each state ...

Financial Assistance ... Program (ODSP) and other low-income Toronto residents may receive help to pay for medical supplies, equipment and devices. Health Support Medication People on Ontario Works ...

pharmaphorum speaks with Steven Davis of AstraZeneca on how the first year of its first direct-to-patient program - ARIMIDEX Direct has been. A year ago, AstraZeneca announced its first direct-to ...

AstraZeneca PLC outperforms 2024 earnings estimates but faces challenges in 2025. Read why AZN patent expiries and mixed ...

AstraZeneca has launched new lawsuits against four generic drug manufacturers in an ongoing patent battle over its cancer drug Lynparza (olaparib), approved to treat ovarian, pancreatic, prostate ...

700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies MISSISSAUGA, ON, Jan. 23, 2025 /CNW ...

Haematologist Dr Sue Pavord was one of the jab’s biggest supporters, but she knew something was wrong when she saw the side-effects up close When Oxford University developed the AstraZeneca ...

AstraZeneca Q4 revenue rose 18% to $14.89 billion, surpassing estimates, with oncology sales up 27% to $6.34 billion. FY25 guidance projects high single-digit revenue growth and low double-digit ...

AstraZeneca announced that this week it has ... enabling full baseline commissioning within NHS England for this patient population. Imfinzi (durvalumab) was recommended by NICE for NHS use ...

Global biopharmaceutical business AstraZeneca will expand its research and development facilities in Mississauga and relocate its Canadian headquarters to a larger, state-of-the-art office. The $820 ...